Abdera Therapeutics
Christine Tseng, PMP, is a seasoned project management professional with extensive experience in the biotechnology and healthcare sectors. Currently serving as a Consultant for Project Management and Process Optimization at Abdera Therapeutics since June 2025, Christine previously held leadership roles at adMare BioInnovations, where responsibilities included managing the Project Management Office and streamlining project governance and processes. With prior experience as a Project Manager at Wax-it Histology Services Inc., Christine oversaw multiple projects and cross-functional teams, ensuring timely and within-budget delivery. Christine's academic credentials include a BSc in Pharmacology from the University of Toronto, along with certifications in Change Management and Project Management from the University of British Columbia.
This person is not in any teams
This person is not in any offices
Abdera Therapeutics
1 followers
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.